Overview

Intradetrusor Botulinum Toxin A: Are Less Injections Better?

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Patients with either overactive bladder (OAB) or urgency urinary incontinence (UUI) with be randomized (like a flip of a coin) to receive 100 units of bladder Botox® at either one injection site or ten injection sites. Efficacy and patient satisfaction will be measured by questionnaires.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Irvine
Collaborators:
Kaiser Permanente
St. Joseph Hospital of Orange
Treatments:
abobotulinumtoxinA
Botulinum Toxins, Type A